Pediatric COVID Outcomes Study (PECOS)

Active, not recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Covid19MIS-C Associated with COVID-19MIS-C Multisystem Inflammatory Syndrome in ChildrenSARS-CoV2 Infection
Trial Locations (2)

20010

Children's National Hospital, Washington D.C.

20852

National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Children's National Research Institute

OTHER